Javier Munoz, MD, MS, FACP
Advertisement
Articles by Javier Munoz, MD, MS, FACP
Javier Munoz, MD, MS, FACP, of the Mayo Clinic, considers the appropriateness for CAR T-cell therapy for a 66-year-old woman with relapsed/refractory mantle cell lymphoma.
Advertisement
Latest Updated Articles
Mantle Cell Lymphoma: Overview and Standard of CareAugust 28th 2020
R/R MCL: Treating With CAR-TAugust 28th 2020
Rationale for CAR-T to Treat R/R MCLAugust 28th 2020
Case Overview: 66-Year-Old Woman With MCLAugust 28th 2020
Next Steps in Research in R/R MCLAugust 28th 2020
R/R MCL: Applying Data Into Clinical PracticeAugust 28th 2020
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
ASCO 2026 GU Cancer Highlights: Beyond the LBAs
2
FDA Approves Generic Eribulin Mesylate for Metastatic Breast Cancer
3
ASCO 2026 GI Cancer Highlights: Beyond the LBAs
4
FDA Grants Fast Track Designation to VS-7375 for KRAS G12D–Mutated NSCLC
5